Generic name:lanadelumab-flyo [ LAN-a-DEL-ue-mab ]
Drug class:Hereditary angioedema agents
Medically reviewed by Drugs.com. Last updated on Nov 2, 2020.
What is Takhzyro?
Takhzyro is a monoclonal antibody that works by reducing the activity of an enzyme that is uncontrolled in people with hereditary angioedema (a rare genetic immune system disorder).
Takhzyro is used to prevent attacks of hereditary angioedema (HAE) in people who are at least 12 years old.
Warnings
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
Before taking this medicine
You should not use Takhzyro if you are allergic to lanadelumab.
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
It may not be safe to breast-feed while using this medicine. Ask your doctor about any risk.
Takhzyro is not approved for use by anyone younger than 12 years old.
How should I use Takhzyro?
Use Takhzyro exactly as it was prescribed for you. Follow all directions on your prescription label and read all medication guides or instruction sheets.
Takhzyro is injected under the skin every 2 to 4 weeks. A healthcare provider may teach you how to properly use the medication by yourself.
Read and carefully follow any Instructions for Use provided with your medicine. Do not use Takhzyro if you don't understand all instructions for proper use. Ask your doctor or pharmacist if you have questions.
Prepare your injection only when you are ready to give it within the next 2 hours.
Store in the refrigerator, do not freeze.
Take the medicine out of the refrigerator and let it reach room temperature for 15 minutes before injecting your dose.
Each single-use via...
